“The U.S. Food and Drug Administration has approved an ovarian cancer drug to help treat advanced pancreatic cancer, a notoriously dangerous form of the disease that’s in need of more effective treatment options.
Earlier this month, a panel of experts at the FDA recommended Lynparza after a study found pancreatic cancer patients taking the drug went nearly twice as long without their cancer getting worse than patients who were taking a placebo.
The FDA went on to approve Lynparza’s use earlier this week as a maintenance treatment for patients with a specific gene mutation whose cancer spread beyond the pancreas, and whose disease did not progress after at least 16 weeks of chemotherapy. Patients will be chosen for therapy based on an FDA-approved diagnostic for the drug.”
View the whole story here: https://thehill.com/changing-america/well-being/medical-advances/476701-fda-green-lights-pancreatic-cancer-drug